# Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Solution
> **Food and Drug Administration** · Final rule. · Published 2008-03-20 · Effective 2008-03-20 · 73 FR 14926
## Document
- **Document number:** E8-5598
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 73 FR 14926
- **CFR reference:** 21 CFR 522
- **Publication date:** 2008-03-20
- **Effective date:** 2008-03-20
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Norbrook Laboratories, Ltd. The supplemental NADA provides for changing scientific nomenclature for a bovine pathogen on labeling for 300 milligrams per milliliter (mg/mL) strength oxytetracycline injectable solution.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2008/03/20/E8-5598/implantation-or-injectable-dosage-form-new-animal-drugs-oxytetracycline-solution)
---
*AI Analytics · CC0 1.0*